On March 07, Shares of Aevi Genomic Medicine, Inc. (GNMX) were valued at $0.21 and moved 3.45% as of a recent closing trade. A total volume of 1.24 million shares were traded versus to average volume of 2.25 million shares.
Aevi Genomic Medicine, Inc. (GNMX) held 65.20 million outstanding shares currently. The company have shares float of 37.35 million. Now have a look at past performance (weekly performance to year to date performance) how Aevi Genomic Medicine, Inc. (GNMX) has been moved; whether it performed well or not. GNMX reported a change of 1.47% over the last week and performed -3.72% over the last month while its year to date (YTD) performance revealed an activity trend of -70.43%. The stock’s quarterly performance specifies a shift of -80.83%, and its last twelve month performance is stands at -89.75% while moved -83.31% for the past six months.
Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. GNMX recently closed with fall of -2.86% to its twenty-Day SMA. This short time frame picture represents a downward movement of current price over average price of last twenty days.
52 week High and Low
Aevi Genomic Medicine, Inc. (GNMX) shares have been seen trading -90.96% off its 52 week- peak value and changed 20.49% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.
Analysts have suggested a mean rating of 2.30 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.
Relative Strength Index (RSI)
Aevi Genomic Medicine, Inc. (GNMX)’s Relative Strength Index (RSI) is 45.99. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for Aevi Genomic Medicine, Inc. (GNMX) is stands at 0.02. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.
Over the past week, the company showed volatility of 7.50%. Moving out to look at the previous month volatility move, the stock is at 9.62%.
Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is 0.33.